홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

Fleroxacin

HCID 3357
새 반응
인쇄
기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
79660-72-3
표준 SMILES
CN1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(CCF)c3c2F)CC1
InChIKey
XBJBPGROQZJDOJ-UHFFFAOYSA-N
분자식
C17H18F3N3O3
평균 분자량
369.34 g/mol
단동위원소 질량
369.1300261

개요

Fleroxacin is a fluoroquinolone antibiotic that is 4-oxo-1,4-dihydroquinoline which is substituted at positions 1, 3, 6, 7 and 8 by 2-fluoroethyl, carboxy, fluoro, 4-methylpiperazin-1-yl and fluoro groups, respectively. It is active against many Gram-positive and Gram-negative bacteria. It has a role as an antibacterial drug, an EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor and a topoisomerase IV inhibitor. It is a monocarboxylic acid, a member of quinolines, a difluorobenzene, a N-alkylpiperazine and a fluoroquinolone antibiotic.

이름 및 식별자

우선 이름
Fleroxacin
IUPAC
6,8-difluoro-1-(2-fluoroethyl)-7-(4-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid
영어명
Fleroxacin
분자식
C17H18F3N3O3
분자량
369.34

이름 및 동의어

fleroxacin79660-72-3MegaloneMegalocinFleroxicinFleroxacinoQuinodisFleroxacineFleroxacinumAM-833AM 833FLRX
이름 더 보기
RO-23-6240ro23-6240/000Fleroxacin>Erlotinib-d12 HClFleroxacin, >=99%
6,8-difluoro-1-(2-fluoroethyl)-7-(4-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acidRo 23-6240/000DTXSID1046714Ro-236240CHEBI:31810Ro-23-6240/000N804LDH51KRo-236240000

데이터베이스 식별자

CAS
79660-72-3
PubChem CID
3357
DTXSID
DTXSID1046714
ChEMBL
CHEMBL6273
ChEBI
CHEBI:31810
UNII
N804LDH51K
EC Number
677-525-2
Nikkaji
J23.768J

물성

구조 계산 물성

XLogP
-0.1
극성 표면적
64.1 Ų
수소 결합 공여자 수
1
수소 결합 수용자 수
9
회전 가능 결합 수
4
무거운 원자 수
26
형식 전하
0
복잡도
595

실험 및 물리화학적 성질

Drugs · 3건

Pharmaceuticals -> Antibiotics

Pharmaceuticals -> Anti infectives for systemic use -> Antibacterials for systemic use

Pharmaceuticals -> Listed in ZINC15

LogP0.04
Human DrugsPharmaceuticals
Dissociation Constants · 4건

8.8

5.5

5.5

8.2

Collision Cross Section189.8 Ų [M+H]+ [CCS Type: TW; Method: calibrated with Waters Major Mix]

물리화학적 성질

녹는점
264 · 264-266°C
끓는 점
535.3 · 535.3±50.0 °C(Predicted)
밀도
1.409 · 1.409±0.06 g/cm3(Predicted)
저장 조건
Sealed in dry,Room Temperature
용해도
0.1 M · 0.1M NaOH: 가용성10mg/mL
산도 계수 (pKa)
-0.54 · -0.54±0.20(Predicted)
물리적 상태
고체
색상
흰색에서 황백색까지

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 4건

Warning

H371 (100%): May cause damage to organs [Warning Specific target organ toxicity, single exposure]

P260, P264, P270, P308+P316, P405, and P501 (click each P-code to see the statement)

The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.

유해성 정보

Hazard Classes and CategoriesSTOT SE 2 (100%)

안전 데이터

wgk
2
rtecs
VB1999050
HS 번호
29335990
스토리지 클래스
11 - Combustible Solids

화학 및 산업

약리 정보

ATC Code · 2건

J - Antiinfectives for systemic use

QJ - Antiinfectives for systemic use

PharmacodynamicsFleroxacin is a broad-spectrum antimicrobial fluoroquinolone. It strongly inhibits the DNA-supercoiling activity of DNA gyrase.
Mechanism of ActionThe inhibition of DNA gyrase and DNA topoisomerase 2 leads ultimately to cell death as these enzymes are required for bacterial DNA replication, transcription, repair, strand supercoiling repair, and recombination.
MeSH Pharmacological Classification · 2건

Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection.

Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II.

Absorption, Distribution and ExcretionRapidly and well absorbed from the gastrointestinal tract after oral administration.

용도 및 제조

Use ClassificationPharmaceuticals
응용 분야 · 1건

개요Fleroxacin is a new, once daily trifluoroquinolone antibacterial structurally related to norfloxacin. Available in both oral and IV formulations, it is reportedly useful in the treatment of gonorrhea, bacterial enteritis, chronic bronchitis and urinary tract infections. Fleroxacin has a longer serum half-life (9-12 hours) than other drugs of this class, such as ciprofloxacin, enoxacin and norfloxacin.

관련 반응

3건
반응 기록 만들기
HRID 373325 반응식
HRID 373325반응물로
HRID 467278 반응식
HRID 467278반응물로
HRID 1728915 반응식
HRID 1728915반응물로

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
Merck
14 · 14,4099
InChI
InChI=1S/C17H18F3N3O3/c1-21-4-6-22(7-5-21)15-12(19)8-10-14(13(15)20)23(3-2-18)9-11(16(10)24)17(25)26/h8-9H,2-7H2,1H3,(H,25,26)
InChIKey
XBJBPGROQZJDOJ-UHFFFAOYSA-N
SMILES
N1(CCF)C2=C(C=C(F)C(N3CCN(C)CC3)=C2F)C(=O)C(C(O)=O)=C1

화학적 성질

White Needle-Like Crystals

상·하류 제품 정보

상류 원료

Fluorobromoethane1-사이클로프로필-6,7-디플루오로-1,4-디하이드로-8-메톡시-4-옥소-3-퀴놀린카르복실산에틸에스테르Quinoline-3-carboxylic acid에틸알코올2,3,4-Trifluorobenzenamine무수초산에톡시메틸렌말론산 디에틸에스테르탄산 칼륨N-메틸피페라진
추가 설명 · 1건

정의ChEBI: A fluoroquinolone antibiotic that is 4-oxo-1,4-dihydroquinoline which is substituted at positions 1, 3, 6, 7 and 8 by 2-fluoroethyl, carboxy, fluoro, 4-methylpiperazin-1-yl and fluoro groups, respectively. It is active against many Gram-positive and Gram-n gative bacteria.